ストックスクリーナーアプリを入手
47.78
0.23%
0.11
アフターアワーズ：
47.78
前日終値:
$47.67
開ける：
$47.55
24時間の取引高:
1.78M
Relative Volume:
1.04
時価総額：
$6.25B
収益：
-
当期純損益:
$-507.65M
株価収益率:
-10.39
EPS:
-4.6
ネットキャッシュフロー:
$-616.24M
1週間 パフォーマンス:
-1.87%
1か月 パフォーマンス:
+12.82%
6か月 パフォーマンス:
+40.65%
1年 パフォーマンス:
-45.94%
1日の値動き範囲:
$47.50
$49.41
1週間の範囲:
$47.02
$50.18
52週間の値動き範囲:
$27.66
$94.76
Vaxcyte Inc Stock (PCVX) Company Profile
名前
Vaxcyte Inc
セクター
電話
650-837-0111
住所
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
PCVX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
47.78 | 6.24B | 0 | -507.65M | -616.24M | -4.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-12 | 開始されました | Goldman | Neutral |
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-20 | 開始されました | Goldman | Buy |
| 2023-12-07 | 開始されました | Mizuho | Buy |
| 2023-04-18 | 開始されました | TD Cowen | Outperform |
| 2023-01-03 | 繰り返されました | Needham | Buy |
| 2022-12-15 | 開始されました | Guggenheim | Buy |
| 2022-11-17 | 開始されました | BTIG Research | Buy |
| 2021-12-29 | 再開されました | Jefferies | Buy |
| 2021-06-24 | 再開されました | Jefferies | Buy |
| 2020-07-07 | 開始されました | BofA Securities | Buy |
| 2020-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-07-07 | 開始されました | Needham | Buy |
すべてを表示
Vaxcyte Inc (PCVX) 最新ニュース
Vaxcyte (PCVX): Evaluating Valuation After a 48% Three-Month Share Price Rebound - Yahoo Finance
How Vaxcyte Inc. stock reacts to Fed rate cutsWeekly Trade Report & Free Technical Pattern Based Buy Signals - newser.com
Is Vaxcyte Inc. stock vulnerable to regulatory risksEarnings Growth Report & Risk Managed Investment Entry Signals - newser.com
Will Vaxcyte Inc. stock continue upward momentumQuarterly Trade Review & Accurate Trade Setup Notifications - newser.com
Is Vaxcyte Inc. (5VA) stock a top hedge fund pickJuly 2025 Action & Momentum Based Trading Ideas - newser.com
PCVX: 31-Valent vaccine nears phase III, targeting major market growth and expanded global demand - TradingView
Vaxcyte stock price target raised to $77 from $60 at Leerink Partners By Investing.com - Investing.com India
Vaxcyte stock price target raised to $77 from $60 at Leerink Partners - Investing.com Canada
What analyst consensus says on Vaxcyte Inc. stockTrade Entry Report & High Conviction Trade Alerts - newser.com
(PCVX) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Can momentum traders help lift Vaxcyte Inc.July 2025 Action & Precise Swing Trade Entry Alerts - newser.com
Is Vaxcyte Inc. stock poised for growthEarnings Trend Report & Daily Technical Forecast Reports - newser.com
Will Vaxcyte Inc. benefit from macro trendsPortfolio Risk Summary & Safe Capital Allocation Plans - newser.com
Vaxcyte Inc Stock Analysis and ForecastStock Split Announcements & High Profit Portfolio Growth - earlytimes.in
Vaxcyte stock up on results from mid-stage trial of its pneumococcal vaccine - MSN
Vaxcyte Inc. (PCVX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Vaxcyte (BIT:1PCVX) Price Target Decreased by 15.42% to 72.37 - Nasdaq
Is Vaxcyte’s (PCVX) Aggressive R&D Spend Still Justified Amid Widening Losses? - simplywall.st
Should you wait for a breakout in Vaxcyte Inc.July 2025 Review & High Conviction Investment Ideas - newser.com
Quantitative breakdown of Vaxcyte Inc. recent move2025 Technical Overview & Real-Time Market Sentiment Alerts - newser.com
Has Vaxcyte Inc. found a price floorBond Market & Smart Investment Allocation Insights - newser.com
Can Vaxcyte Inc. (5VA) stock attract analyst upgrades2025 Performance Recap & AI Powered Buy and Sell Recommendations - newser.com
Using data tools to time your Vaxcyte Inc. exitChart Signals & Daily Market Momentum Tracking - newser.com
Will Vaxcyte Inc. stock benefit from commodity prices2025 Price Momentum & Risk Controlled Stock Alerts - newser.com
Vaxcyte’s Stock Juggle: Opportunity or Risk? - StocksToTrade
What moving averages say about Vaxcyte Inc.Market Rally & Reliable Breakout Forecasts - newser.com
When is the best time to exit Vaxcyte Inc.Market Activity Recap & Free Fast Gain Swing Trade Alerts - newser.com
Vaxcyte Inc (PCVX) 財務データ
収益
当期純利益
現金流量
EPS
Vaxcyte Inc (PCVX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| GUGGENHIME ANDREW | PRESIDENT AND CFO |
Apr 07 '25 |
Option Exercise |
20.93 |
4,777 |
99,983 |
131,950 |
| PICKERING GRANT | CHIEF EXECUTIVE OFFICER |
Apr 04 '25 |
Option Exercise |
8.96 |
20,533 |
183,888 |
518,775 |
| Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC |
Mar 05 '25 |
Option Exercise |
21.41 |
5,000 |
107,050 |
46,620 |
| Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC |
Mar 05 '25 |
Sale |
70.74 |
5,000 |
353,699 |
41,620 |
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):